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Abstract 
 
In an acute care setting, chemical asphyxiants (CA) are culprits for debilitating injury. Carbon 
monoxide (CO) is one well known CA which causes hypoxic injury to cardiovascular and 
neurological tissue. CO poisoning is one of the leading causes of death in USA. As many as 6% 
of patients who get admitted with CO poisoning in the USA have acute myocardial infarction. A 
strong positive correlation of CO Hb concentration has been established with increased incidence 
of myocardial infarctions (MI). We present a case of a 75-year-old male with complaints of chest 
discomfort, dyspnea, diaphoresis that was attributed to CO poisoning. Over the course of his stay 
he had two sets of positive serial troponins and was diagnosed with a non-ST elevation MI. Most 
of the recent literature focuses on ST elevation and T wave inversions in patients with CO 
poisoning. Contrary to this, our patient did not exhibit any EKG changes at any point during his 
hospital course. CO poisoning can cause fatal complications including an MI. 
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Background 
 
In an acute care setting, chemical asphyxiants (CA) are culprits for debilitating injury. Carbon 
monoxide (CO) is one well known CA which causes hypoxic injury to cardiovascular and 
neurological tissue.1 CO is a colorless, non-irritating, odorless gas with a density of 0.97, which 
has the potential to go undetected and cause serious complications.2 CO causes injury because it 
has 60 times higher affinity to bind with oxygen carrying proteins (hemoglobin and myoglobin), 
leading to the formation of carboxyhemoglobin (COHb), thereby reducing the oxygen available 
to the mitochondria and leading to impaired oxidative phosphorylation.3 An additive pathway for 
CO to injure cells is by direct toxic injury to mitochondria at the level of cytochrome c oxidase.2 
A strong positive correlation of COHb concentration has been established with increased 
incidence of myocardial infarctions (MI).4 We present a case of a 75-year-old male with 
incidental CO poisoning who sustained a non-ST elevation myocardial infarction (NSTEMI).      
 
Case 
 
A 75-year-old Caucasian male with a past medical history significant for hypertension and a 75 
pack year history of smoking presented to the emergency department at 2030 via emergency 
medical services (EMS) after complaining of dyspnea, dizziness, nausea, diaphoresis, and chest 
discomfort. He reported that he was working on his automobile in an unventilated garage with 
the doors closed. Incidentally, his engine was running for approximately 10 minutes until he 
noted the aforementioned symptoms. He immediately left the garage and called the EMS. He 
described the chest pain as pressure like which spread across his chest.  When EMS arrived he 
was given supplemental oxygen; this helped to quell his symptoms which had largely resolved 
by the time he arrived at the ED. 
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 On arrival his blood pressure was 162/91 mmHg, his heart rate was 97 bpm, and his respiratory 
rate was 20 bpm with an oxygen saturation of 97%. He was provided 100% supplemental oxygen 
via a non-rebreather mask. His laboratory workup was significant for CO level of 19.9%, a 
serum troponin I of 1.146 ng/dL and a serum creatinine of 1.45 mg/dL. His ABG demonstrated a 
pH of 7.45, a pCO2 of 38 mmHg, and a pO2 of 130 mmHg. His EKG did not suggest any acute 
changes except for a potential prior inferior wall MI (Figure 1). He was admitted to the ICU at 
2150 and the cardiology team was consulted. Oxygen saturation measured by pulse oximetry 
consistently yielded 100%. Repeat serum troponin I levels were collected at T+2 hour and T+4 
hour intervals resulting in significant elevations, to 10.6 ng/mL and 12.7 ng/mL respectively. 
The diagnosis of Type 2 NSTEMI was applied, and a weight-based heparin infusion was started. 
 
 
His CO was assessed after every three hours, which showed progressive improvement to levels 
of 7.7% at 0016 and 4.7% at 0336 hours. At approximately 0500 hours he complained of mild 
chest discomfort. Following examination, a repeat EKG was ordered, and serum troponin I levels 
again trended, resulting in 20.6 ng/mL, 21.4 ng/mL, and 20.4 ng/mL at T+0, T+2, and T+4 hours 
respectively.  
 
The patient’s CO levels improved and reached 3.7% at 0632. The patient continued to receive 
supplemental oxygen via a 100% non-rebreather mask. Upon further inquiry, the patient revealed 
an undocumented history of MI in the past. An echocardiogram was obtained and demonstrated 
an ejection fraction (EF) of >55% and a right ventricular systolic pressure (RVSP) of 26.8 
mmHg with no apparent wall motion defect. He was continued on a heparin infusion and 
remained symptom free. A nuclear myocardial perfusion scan was performed and suggested no 
evidence of myocardial infarction or ischemia, with an EF of 54%. The patient’s CO levels 
reached 1.2% just prior to discharge. EKG done prior to discharge did not show any changes 
(Figure 2). 
 
 
 
 
Figure 1 EKG on presentation, showing nonspecific changes 
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Figure 2 EKG on discharge 
 
Discussion 
 
CO and its association with myocardial ischemia and infarction has been studied and reported 
previously. Mujib et al reported that 6% of patients had acute myocardial infarctions after CO 
poisoning, and out of those 9% had in-hospital mortality.5 The most plausible hypothesis 
suggests that COHb diminishes oxygen transportation, leading to myocardial tissue hypoxia.1,2,4 
Other studies have also proposed that CO induces vasospasm, reduces blood flow, and increases 
permeability of the coronary vasculature, thereby promoting platelet aggregation and thrombus 
formation.2 Kaya et al discussed that CO inhibits mitochondrial cytochrome c oxidase which 
reduces the level of glutathione, which in turn causes hypoxia, lactic acidosis, and eventually 
apoptosis in cells.4  
 
Satran et al studied moderate to severe CO poisoning and serum troponin levels in 230 patients 
and found that 35% of the patients with CO poisoning have elevated serum troponin levels.6  The 
trend of elevation in serum troponin levels in our patient was similar to the trend previously 
reported, which spans from 2-8 hours.1,7,8  The rise in troponin levels correlates to the half life of 
CO in patients. It has been reported that CO has a half life of 300 minutes if the patient is 
breathing room air, though this is decreased to 90 minutes with use of a non-breather mask and 
30 minutes if hyperbaric oxygen treatment is provided.9 Considering the time needed for the 
serum troponin level to rise after myocardial injury and the half-life of CO, it could be 
hypothesized that a patient should demonstrate a rise in serum troponin levels in approximately 
2-8-hours after exposure. 
 
Most of the recent literature focuses on ST elevation and T wave inversions in patients with CO 
poisoning.7,8,9,10 Contrary to this, our patient did not exhibit any EKG changes at any point 
during his hospital course. It is reported that other cardiac groups may not show any ischemic 
changes on EKG. Rab et al reported that in patients with a cardiac arrest and no STEMI on EKG, 
approximately 33% have a culprit vessel and 70% of those are occluded.11 Rasoul et al found 
that non-diagnostic EKGs (no ST elevation) were present in 18% of patients with a left 
circumflex related infarct and in 7% of the right coronary artery related infarcts.12 This shows 
that a non-ischemic EKG does not automatically exclude on going ischemia. 
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As concluded by Buckley et al in a recent Cochrane review, supplemental 100% oxygen delivery 
via a non-rebreather mask remains the mainstay of treatment in CO poisoning.13 Patients with ST 
elevation should receive coronary angiography, as CO poisoning is known to exacerbate 
underlying coronary arteriosclerosis.1,9 While hospitalized with a non-ST elevation MI, an 
echocardiogram and nuclear stress test should be considered, as these modalities would be more 
cost effective and predictive of cardiac function. Our patient did not demonstrate any apparent 
wall motion abnormalities and had an EF of >55%, which did not warrant additional 
intervention.  
 
Conclusion 
 
CO poisoning can cause fatal complications for patients, hence diagnostic vigilance is required 
for physicians who encounter such patients, especially during winter months. Modalities such as 
EKG, echocardiogram, and serum cardiac markers should be utilized to assess cardiac function. 
Coronary angiography should be performed in accordance with the guidelines of American 
College of Cardiology. Utilization of hyperbaric oxygen therapy should be considered, but more 
research is required to establish use of hyperbaric oxygen treatment in patients with CO 
poisoning and myocardial ischemia. 
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